CClinicalTrials.gg
TerminatedNCT01714791OSTinCAREUpdated Mar 5, 2018

Effects of Osteopathic Treatment on Pulmonary Function After Coronary Artery Bypass Graft Surgery

An interventional study of Usual care and Osteopathic treatment in Mechanical Complication of Coronary Artery Bypass Graft, Respiratory Depression and Pain, sponsored by Hartcentrum Hasselt. Terminated at 1 site in Belgium. Per ClinicalTrials.gov, last updated 2018-03-05.

Sponsored by Hartcentrum Hasselt · Not applicable, Interventional, and Treatment

Why this study was terminated
Lack of new inclusions due to a significant change in surgery technique. An endoscopic a-traumatic coronary artery bypass (endo-ACAB) approach is now used.
Phase
Not applicable
Study type
Interventional
Enrollment
112
Allocation
Randomized
Sex
All
01

Study summary

The purpose of this study is to determine the short and long term effects of osteopathic treatment on pulmonary function, pain and quality of life in patients after coronary artery bypass graft (CABG) surgery. The study is a randomized controlled trial.

Read the detailed description

Coronary artery bypass graft (CABG) surgery is performed worldwide. Several studies have found that there is a decrease in pulmonary function, loss of thoracic mobility and a high prevalence of chronic poststernotomy pain (CPSP) after CABG. So far there is no effective treatment for these conditions. The OstinCare study aims to investigate whether osteopathic treatment has an added value in the treatment of these patients.

02

Conditions studied

  • Mechanical Complication of Coronary Artery Bypass Graft
  • Respiratory Depression
  • Pain
  • Quality of Life

Keywords

  • Coronary Artery Bypass Graft
  • Osteopathic Medicine
  • Vital Capacity
  • Quality of Life
  • Cardiac rehabilitation
03

In context

Respiratory Insufficiency

1,650 studies on the registry are indexed under Respiratory Insufficiency; 297 are open to participants now.

This study's enrollment of 112 is above the median of 55 across 1,042 interventional studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

Hartcentrum Hasselt is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Planned Coronary Artery Bypass Graft (CABG) surgery at the Jessa Hospital Hasselt
  • Planned Endoscopic Atraumatic Coronary Artery Bypass (endo ACAB) surgery at the Jessa Hospital
  • Planned Minimal Invasive Aortic Valve Replacement (mini AVR) surgery at the Jessa Hospital

Exclusion criteria

Exclusion Criteria:

  • Thoracic surgery in the past
  • Redo CABG
  • Complications after CABG, requiring long-term (more than 6 days) admission to intensive care
  • Pathologies of the lungs
  • Pathologies of the heart, other than the coronary artery disease
  • Surgery in the sub diaphragmatic region: epigastric region, left and right hypochondriac region.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
112 participants (actual)

Study arms

  • Active comparator
    Usual care

    Patients following the outpatient cardiac rehabilitation program.

    Other: Usual care

  • Experimental
    Usual care and Osteopathic treatment

    Patients following the outpatient cardiac rehabilitation program and receiving osteopathic treatment.

    Other: Usual care · Other: Osteopathic treatment

Interventions

  • OtherUsual care

    Patients exercise at a heart rate corresponding to 65% of baseline Vo2peak. Each exercise training session takes 40-60 minutes. Exercise time is apportioned as follows: 42% on the treadmill, 33% on the circle ergometer and 25% on the arm cranking device. All patients exercise under close supervision 3 days per week for a total duration of 12 weeks.

    Also known as: Outpatient cardiac rehabilitation

  • OtherOsteopathic treatment

    Patients receive 4 osteopathic treatments (OT). OT is performed in week 4, 5, 8 and 12 postoperative. Depending on what is found in the patient, treatments consist mostly of one or more of the following approaches: * Structural High Velocity Low Amplitude-techniques. * Muscle Energy Techniques. * General osteopathic mobilisations. * Functional techniques (Sutherland-, Jones-techniques,...) including inhibition techniques. * Fascia techniques. * Soft tissue- and connective tissue techniques. * Neurovisceral and neurolymphatic reflex techniques. * Fluidal techniques (lymphatic manipulative techniques,...). * Visceral manipulations. * Neurocranial and viscerocranial techniques.

06

What researchers measure

Primary outcomes

  1. Change from baseline in slow vital capacity (SVC) at 12 weeks.

    A Slow Vital Capacity (SVC) test will be performed at each time point.

    Time frame: preoperative (baseline) and 12 weeks postoperative

Secondary outcomes

  1. Change from baseline in slow vital capacity (SVC) at 52 weeks.

    A SVC test will be performed at each time point.

    Time frame: preoperative (baseline) and 52 weeks postoperative

  2. Change from baseline in McNew quality of life questionnaire at 12 weeks.

    McNew questionnaire will be done at 3 and 12 weeks after surgery.

    Time frame: 3 weeks postoperative (baseline) and 12 weeks postoperative

  3. Change from baseline in McNew quality of life questionnaire at 52 weeks.

    McNew questionnaire will be done at 3, 12 and 52 weeks after surgery.

    Time frame: 3 weeks postoperative (baseline) and 52 weeks postoperative

  4. Change in pain from baseline on Visual Analogue Scale (VAS) at 12 weeks postoperative.

    Pain will be evaluated at 3 and 12 weeks after surgery.

    Time frame: 3 weeks postoperative (baseline) and 12 weeks postoperative

  5. Change in pain from baseline on VAS at 52 weeks postoperative.

    Pain will be evaluated at 3, 12 and 52 weeks after surgery.

    Time frame: 3 weeks postoperative (baseline) and 52 weeks postoperative

  6. Change in thoracic stiffness from baseline on VAS at 12 weeks postoperative.

    Thoracic stiffness will be evaluated at 3, 12 weeks after surgery.

    Time frame: 3 weeks postoperative (baseline) and 12 weeks postoperative

  7. Change in thoracic stiffness from baseline on VAS at 52 weeks postoperative.

    Thoracic stiffness will be evaluated at 3, 12 and 52 weeks after surgery.

    Time frame: 3 weeks postoperative (baseline) and 52 weeks postoperative

Other outcomes

  1. Change from baseline in maximal aerobic capacity (VO2max) at 12 weeks postoperative

    All patients will perform a maximal cardiopulmonary exercise test on a cycle ergometer. The test will be performed at the cardiac rehabilitation centre by a trained operator and under supervision of a cardiologist.

    Time frame: 3 weeks postoperative (baseline) and 12 weeks postoperative

  2. Changes in thoracic mobility at 4, 12 and 52 weeks postoperative.

    Osteopathic clinical examination of the thorax.

    Time frame: 4, 12 and 52 weeks postoperative

07

Study locations

1 site
  • Cardiac rehabilitation centre at the Jessa Hospital Hasselt
    Hasselt, Limburg 3500, Belgium
08

References and documents

Publications

  • Kristjansdottir A, Ragnarsdottir M, Hannesson P, Beck HJ, Torfason B. Chest wall motion and pulmonary function are more diminished following cardiac surgery when the internal mammary artery retractor is used. Scand Cardiovasc J. 2004 Dec;38(6):369-74. doi: 10.1080/14017430410016396. PubMed 15804805 ↗
  • Kristjansdottir A, Ragnarsdottir M, Hannesson P, Beck HJ, Torfason B. Respiratory movements are altered three months and one year following cardiac surgery. Scand Cardiovasc J. 2004 May;38(2):98-103. doi: 10.1080/14017430410028492. PubMed 15204235 ↗
  • Ragnarsdottir M, Kristinsdottir EK. Breathing movements and breathing patterns among healthy men and women 20-69 years of age. Reference values. Respiration. 2006;73(1):48-54. doi: 10.1159/000087456. Epub 2005 Aug 11. PubMed 16106113 ↗
  • Ragnarsdottir M, KristjAnsdottir A, Ingvarsdottir I, Hannesson P, Torfason B, Cahalin L. Short-term changes in pulmonary function and respiratory movements after cardiac surgery via median sternotomy. Scand Cardiovasc J. 2004 Mar;38(1):46-52. doi: 10.1080/14017430310016658. PubMed 15204247 ↗
  • Bruce J, Drury N, Poobalan AS, Jeffrey RR, Smith WC, Chambers WA. The prevalence of chronic chest and leg pain following cardiac surgery: a historical cohort study. Pain. 2003 Jul;104(1-2):265-73. doi: 10.1016/s0304-3959(03)00017-4. Erratum In: Pain. 2004 Dec;112(3):413. PubMed 12855337 ↗
  • Kalso E, Mennander S, Tasmuth T, Nilsson E. Chronic post-sternotomy pain. Acta Anaesthesiol Scand. 2001 Sep;45(8):935-9. doi: 10.1034/j.1399-6576.2001.450803.x. PubMed 11576042 ↗
  • Locke TJ, Griffiths TL, Mould H, Gibson GJ. Rib cage mechanics after median sternotomy. Thorax. 1990 Jun;45(6):465-8. doi: 10.1136/thx.45.6.465. PubMed 2392792 ↗
  • Mazzeffi M, Khelemsky Y. Poststernotomy pain: a clinical review. J Cardiothorac Vasc Anesth. 2011 Dec;25(6):1163-78. doi: 10.1053/j.jvca.2011.08.001. Epub 2011 Sep 29. No abstract available. PubMed 21955825 ↗
  • Meyerson J, Thelin S, Gordh T, Karlsten R. The incidence of chronic post-sternotomy pain after cardiac surgery--a prospective study. Acta Anaesthesiol Scand. 2001 Sep;45(8):940-4. doi: 10.1034/j.1399-6576.2001.450804.x. PubMed 11576043 ↗
  • van Gulik L, Janssen LI, Ahlers SJ, Bruins P, Driessen AH, van Boven WJ, van Dongen EP, Knibbe CA. Risk factors for chronic thoracic pain after cardiac surgery via sternotomy. Eur J Cardiothorac Surg. 2011 Dec;40(6):1309-13. doi: 10.1016/j.ejcts.2011.03.039. Epub 2011 May 10. PubMed 21561786 ↗
  • van Leersum NJ, van Leersum RL, Verwey HF, Klautz RJ. Pain symptoms accompanying chronic poststernotomy pain: a pilot study. Pain Med. 2010 Nov;11(11):1628-34. doi: 10.1111/j.1526-4637.2010.00975.x. PubMed 21044253 ↗
  • Westerdahl E, Lindmark B, Bryngelsson I, Tenling A. Pulmonary function 4 months after coronary artery bypass graft surgery. Respir Med. 2003 Apr;97(4):317-22. doi: 10.1053/rmed.2002.1424. PubMed 12693792 ↗
  • Hansen D, Dendale P, Berger J, Meeusen R. Rehabilitation in cardiac patients:what do we know about training modalities? Sports Med. 2005;35(12):1063-84. doi: 10.2165/00007256-200535120-00005. PubMed 16336009 ↗
  • Alston RP, Pechon P. Dysaesthesia associated with sternotomy for heart surgery. Br J Anaesth. 2005 Aug;95(2):153-8. doi: 10.1093/bja/aei152. Epub 2005 May 13. PubMed 15894562 ↗
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available. PubMed 16055882 ↗
  • Roncada G. Osteopathic treatment leads to significantly greater reductions in chronic thoracic pain after CABG surgery: A randomised controlled trial. J Bodyw Mov Ther. 2020 Jul;24(3):202-211. doi: 10.1016/j.jbmt.2020.03.004. Epub 2020 Mar 17. PubMed 32825989 ↗
  • Roncada G. Effects of osteopathic treatment on pulmonary function and chronic thoracic pain after coronary artery bypass graft surgery (OstinCaRe): study protocol for a randomised controlled trial. BMC Complement Altern Med. 2016 Nov 25;16(1):482. doi: 10.1186/s12906-016-1468-3. PubMed 27884147 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01714791
Lead sponsor
Hartcentrum Hasselt
Responsible party
Roncada Gert (Principal Investigator, Hartcentrum Hasselt) — Principal investigator
First posted
Oct 26, 2012
Start date
Jan 2010
Primary completion
Dec 2017
Completion
Dec 2017
Last update
Mar 5, 2018

Study contacts

Gert Roncada, DO, MSc
principal investigator · Heart Centre Hasselt

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion